Filing Flows › West Pharmaceutical Services (WST) › Free cash flow
West Pharmaceutical Services (WST) free cash flow by quarter
West Pharmaceutical Services' free cash flow was $150M in Q3 2026 (third quarter 2026), +86% from Q2 2026. Over the last 7 quarters it ranged from $47.2M (Q1 2026) to $175M (Q4 2025).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $150M | +86% | +12% |
| Q2 2026 | $80.8M | +71% | -21% |
| Q1 2026 | $47.2M | -73% | -19% |
| Q4 2025 | $175M | +31% | — |
| Q3 2025 | $134M | +31% | — |
| Q2 2025 | $102M | +75% | — |
| Q1 2025 | $58.1M | — | — |
Q3 2026 at a glance
West Pharmaceutical Services, Q3 2026: revenue $874M (+9% year over year), operating margin 30.6%, net earnings $214M, operating cash flow $190M. The chart follows the revenue to costs, profit and cash.
Questions
What is West Pharmaceutical Services' free cash flow?
West Pharmaceutical Services' free cash flow was $150M in Q3 2026 (third quarter 2026), +86% from Q2 2026.
How has West Pharmaceutical Services' free cash flow changed?
Over the last 7 quarters it ranged from $47.2M (Q1 2026) to $175M (Q4 2025).
Q3 2026 results → · How West Pharmaceutical Services makes money →